# HANPOONG PHARM CO.,LTD. · 99-39 · KOREA (THE REPUBLIC OF) — FDA import alert red lists: firms subject to detention without physical examination

For HANPOONG PHARM CO.,LTD. · 99-39 · KOREA (THE REPUBLIC OF), import alert is 99-39; import alert name is Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded; country is KOREA (THE REPUBLIC OF); product code is 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human); date published is 08/14/2017; address is 11 Guretdeul 3-Gil Deokjin-Gu , Jeonju, KOREA (THE REPUBLIC OF), verified against its source on 2026-09-16.

- **Firm:** HANPOONG PHARM CO.,LTD. _(verified: appears in the quote below)_
- **Import alert:** 99-39
- **Import alert name:** Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded
- **Country:** KOREA (THE REPUBLIC OF) _(verified: appears in the quote below)_
- **Address:** 11 Guretdeul 3-Gil Deokjin-Gu , Jeonju, KOREA (THE REPUBLIC OF) _(verified: appears in the quote below)_
- **Date published:** 08/14/2017 _(verified: appears in the quote below)_
- **Product code:** 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) _(verified: appears in the quote below)_
- **FDA notes:** DaChaiHe Tang (also known as DaChaiHu Tang); Section 403(s)(2)(B) of the Act in that the label of the dietary supplement fails to identify the product by using the term "dietary supplement" in accordance with 21 CFR 101.3(g). Section 403(q)(5)(F) of the Act in that the presentation of the nutrition information on the labeling of the product does not comply with 21 CFR 101.36. Section 403(i)(2) of the Act [21 U.S.C.§343(i)(2)], in that each ingredient is not declared by its common or usual name in accordance with 21 CFR 101.4 Section 403(s)(2)(A)(ii)(I) of the Act in that it fails to include the quantitative amount by weight per serving size of all the dietary ingredients as required by 21CFR 101.36. Section 403(s)(2)(C) of the Act because the label fails to identify the part of the plant from which all the botanical dietary ingredients in the product are derived as required by 21CFR 101.4(h)(1). Section 403(q) of the FD&C Act in that the required nutrition information is not in the appropriate format in accordance with 21 CFR 101.9. Section 403(f) of the Act [21 U.S.C. 343(f)] in that the product label contains information in two languages but does not repeat all the required label information in both languages as required by 21CFR 101.15(c). Section 403(e)(2) of the Act because the label fails to declare the net quantity of contents on the principal display panel as required by 21 CFR 101.7. _(verified: appears in the quote below)_

## What the source says

> HANPOONG PHARM CO.,LTD. Date Published : 08/14/2017 11 Guretdeul 3-Gil Deokjin-Gu , Jeonju, KOREA (THE REPUBLIC OF) 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) Date Published: 08/14/2017 Notes: DaChaiHe Tang (also known as DaChaiHu Tang); Section 403(s)(2)(B) of the Act in that the label of the dietary supplement fails to identify the product by using the term "dietary supplement" in accordance with 21 CFR 101.3(g). Section 403(q)(5)(F) of the Act in that the presentation of the nutrition information on the labeling of the product does not comply with 21 CFR 101.36. Section 403(i)(2) of the Act [21 U.S.C.§343(i)(2)], in that each ingredient is not declared by its common or usual name in accordance with 21 CFR 101.4 Section 403(s)(2)(A)(ii)(I) of the Act in that it fails to include the quantitative amount by weight per serving size of all the dietary ingredients as required by 21CFR 101.36. Section 403(s)(2)(C) of the Act because the label fails to identify the part of the plant from which all the botanical dietary ingredients in the product are derived as required by 21CFR 101.4(h)(1). Section 403(q) of the FD&C Act in that the required nutrition information is not in the appropriate format in accordance with 21 CFR 101.9. Section 403(f) of the Act [21 U.S.C. 343(f)] in that the product label contains information in two languages but does not repeat all the required label information in both languages as required by 21CFR 101.15(c). Section 403(e)(2) of the Act because the label fails to declare the net quantity of contents on the principal display panel as required by 21 CFR 101.7.

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_1144.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).